The new dates are: May 11 – 13, 2021

Colleagues who have questions can contact the conference secretariat by email at

Biomed News

Welcome Letter from Co-Chairpersons

It is our honor and pleasure to invite you to participate in the 19th MIXiii-BIOMED Conference and Exhibition, to be held May 11-13, 2021 in Tel Aviv, Israel.

Explore MIXiii BIOMED 2021 Conference Tracks

Featuring 9 tracks of programming, the MIXiii BIOMED 2021 Conference invites attendees to explore what’s next in the worlds of Biotechnology and Life Sciences.

Previous Events

18th National Life Sciences & Technology Week

May 14 – 16, 2019 | David InterContinental Tel Aviv, Israel

17th National Life Sciences & Technology Week

May 15 – 17, 2018 | David InterContinental Tel Aviv, Israel

May 23-25, 2017 David InterContinental Tel Aviv, Israel

16th National Life Science & Technology Week

Plenary Speakers

Robert Cohen
VP of Global R&D, Chief Technology Officer, Stryker Joint Replacement

Amy Schulman
Managing Partner, Polaris Partners


Prof. Robert Langer
Institute Professor at MIT, MIT Department of Chemical Engineering


Andrew “Cal” Callaway
Managing Director, U.S. Healthcare Investment Banking, Royal Bank of Canada (RBC)


Prof. Yitshak Kreiss, MD
Director General, Sheba Medical Center

Aharon Aharon
CEO, Israel Innovation Authority (IIA)

Jeremy Levin_150x200 (1)

Jeremy M. Levin, DPhil, MB BChir
CEO and Chairman, Ovid Therapeutics

Tracks & Track Chairs

DAY 1: TUESDAY, May 11

Robotics Role in Future Healthcare Systems
Chair: Ori Hadomi
VP New Business Development & Partnerships, Medtronic

Longevity – How to Die Young at a Very Old Age
Co-Chairs: Anat Naschitz
Managing Director, OrbiMed Advisors
Nir Barzilai, MD
Rennert Professor of Aging, Albert Einstein College of Medicine
Yael Benvenisti, PhD
CEO, Mediterranean Towers Ventures

Next Generation BioTherapeutics – Gene Editing, RNAi, Oligos, Cell and Gene Therapies, Microbiome and others
Co-Chairs: Yaron Carmi, PhD
Assistant Professor, Sackler School of Medicine, Tel Aviv University
Jonathan Solomon
CEO, BiomX


AI Technology Redefining the Future of Biopharma, Care Delivery, and Holistic Medicine
Co-Chairs: Iris Grossman, PhD
Chief Scientific Officer, Camp4 Therapeutics
Tamara Mansfeld
Global Innovation Lead, Digital Innovation Lab, Pfizer 

Decoding the Brain Enigma: Parkinson’s, Alzheimer’s, ALS, Mental Disorders
Co-Chairs: Barry Greene
President, Alnylam Pharmaceuticals
Dekel Taliaz, PhD
Co-Founder and CEO, Taliaz

Bright Spots Illuminating the Future of Medical Devices
Co-chairs: Irit Yaniv, MD
Managing Partner, Accelmed Ventures Fund
James Eadie, MD
Partner, Santé Ventures

DAY 3: Thursday, May 13 

Targeted Cancer Treatment; Cure? Maintenance? – Has Medicine Reached these Points?
Chair: Prof. David Sidransky, MD,
Johns Hopkins School of Medicine; Co-Founder & General Partner, Israel Biotech Fund

Exact and Biological Science Diagnostics – Sensors, Genomics, AI, Imaging, and others
Co-Chairs: Prof. Varda Shalev, MD, MPA
Head, KSM Kahn – Sagol – Maccabi Research & Innovation Institute
Yair Schindel, MD
Managing Partner & Co-Founder, aMoon Fund

Bio-convergence – Biologically Inspired Engineering Reshaping Future Medicine
Chair: Omri Amirav-Drory, PhD,
Founding General Partner, Tech.Bio Fund


Invited Speakers (Preliminary List)

Federico Goodsaid, PhD
Ex-FDA & Senior VP Regulatory Affairs, Ariana Pharma

Dimitris Agrafiotis, PhD
Chief Information Officer, Novartis Institutes for BioMedical Research (NIBR)

Rosana Kapeller-Libermann, PhD
EIR, Google Ventures

Daphna Laifenfeld, PhD
Chief Strategy Officer, Ibex Medical Analytics

Michal Ozery-Flato, PhD
Machine Learning Researcher, IBM Haifa Research Lab

Eric de La Fortelle, PhD
Venture Partner, Seventure

Pierre Belichard
CEO, Enterome

Jeremy M. Levin, DPhil, MB BChir
CEO and Chairman, Ovid Therapeutics

Prof. Amir Lerman, MD
Cardiovascular Diseases and Internal Medicine, Mayo Clinic

Prof. Tamar Flash, PhD
Department of Computer Science and Applied Mathematics, Weizmann Institute of Science

Wenbo Liu
Co-Founder & Chief Technology Officer, Sinovation (Beijing) Medical Technology Co., LTD

Allitia DiBernardo, MD
Global Medical Affairs Lead, Neurosciences, The Janssen Pharmaceutical Companies of Johnson & Johnson

Prof. Peter A. Noseworthy, MD
Department of Cardiovascular Medicine, Mayo Clinic

Miro Venturi, PhD, MSc
Senior Vice President & Head, Biopharma, Foundation Medicine

Barry Greene
President, Alnylam Pharmaceuticals

Laura Lande-Diner, PhD
Director of Innovation, Integral Health

Hakan Sakul, PhD
Vice President and Head of Diagnostics, Pfizer Inc, Worldwide R&D – La Jolla Laboratories

Richard Kendall, PhD
CEO, ImmPACT Bio Inc

Megan Rosengarten
VP / General Manager, Surgical Robotics, Medtronic

Mehmood Khan
Chief Executive Officer Life, Biosciences

Steve Austad, PhD
Distinguished Professor and Chair of the Department of Biology, University of Alabama at Birmingham

James Peyer, PhD
Founder and Managing Partner, Kronos BioVentures

Joan Mannick, MD
Chief Medical Officer, resTORbio

Zan Fleming, MD
Founder and Executive Chairman, Kinexum

Rafael de Cabo, PhD
Senior Investigator, Translational Gerontology Branch, NIH

Prof. Eran Segal, PhD
Department of Computer Science and Applied Math, Weizmann Institute

Michael Alonso, PhD
VP of Immunology & Pharmacology & Co-Founder, Bolt Biotherapeutics

Johan Luthman
Executive VP, R&D, H. Lundbeck A/S

Devi Prasad Shetty, MBBS, MS, FRCS
Chairman & Founder, Narayana Health

Director of Cardiovascular Research, Education & Technology, John Muir Health Cardiovascular Institute; Life Science Angels – Medical Device & Digital Health Committee

John J. Smith, MD, JD
Partner, Hogan Lovells


MIXiii Biomed 2021 Sponsors

The conference serves as a meeting point for local and multinational companies, venture capitalists, private equity investors, corporate and institutional investors, technology transfer experts, licensing executives, business development executives, university, government and corporate research scientists and government representatives.

Diamond Sponsor


Gold SponsorS


Media Partner